Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.,Cytometry Part A

当前位置： X-MOL 学术 › Cytom. Part A › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.
Cytometry Part A ( IF 2.5 ) Pub Date : 2020-04-10 , DOI: 10.1002/cyto.a.24009
Andrea Cossarizza _{1,

2} , Lara Gibellini ₁ , Sara De Biasi ₁ , Domenico Lo Tartaro ₁ , Marco Mattioli ₁ , Annamaria Paolini ₁ , Lucia Fidanza ₁ , Caterina Bellinazzi ₁ , Rebecca Borella ₁ , Ivana Castaniere ₃ , Marianna Meschiari ₄ , Marco Sita ₅ , Gianrocco Manco ₆ , Enrico Clini ₃ , Roberta Gelmini ₆ , Massimo Girardis ₅ , Giovanni Guaraldi ₄ , Cristina Mussini ₄

Affiliation

The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. © 2020 International Society for Advancement of Cytometry

中文翻译：

处理和处理 COVID-19 患者的血液样本，以进行细胞表型和细胞因子风暴的安全研究。

由严重急性呼吸综合征冠状病毒2引起的大流行严重影响了所有在实验室工作的人员。来自已知感染患者或被认为健康的捐赠者的样本可以到达，而同事可能没有症状但能够传播病毒。在临床实验室工作面临着一些安全挑战。几年前，国际细胞计数促进会发布了安全分析和分类人体样本的指南，这些指南最近进行了修订。我们描述了自意大利出现第一例患者以来我们一直遵循的程序，这些程序仅稍微修改了我们的标准程序，即所有人体样本都与风险相关。© 2020 国际细胞计数促进会

更新日期：2020-04-10

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11